G9a/EHMT2 Antibody
Selleck Chemicals
SKU:F3368-20UL
Couldn't load pickup availability

About the Target
EHMT2 (Euchromatic histone-lysine N-methyltransferase 2), commonly known as G9a, is a key histone methyltransferase encoded by the EHMT2 gene in humans. It primarily catalyzes the mono- and di-methylation of histone H3 at lysine 9 (H3K9me1 and H3K9me2), epigenetic modifications typically associated with transcriptional repression within euchromatin. Depending on the literature source, EHMT2 may also be discussed as G9a/EHMT2 and BAT8.
Reported cellular context includes chromosome and nucleus, which can matter when signal is compared across treatments or changing cell states. Following EHMT2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.
Research Context
EHMT2 is commonly interpreted in the context of cancer, immunology, and developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans chromosome and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.
Consider these angles when interpreting target-level changes:
- apparent redistribution between chromosome and nucleus across matched conditions
- changes associated with proliferative state, oncogenic signaling, or treatment response
- context differences tied to immune-cell state, activation, or lineage composition
- stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
Variant Considerations
If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EHMT2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.
Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EHMT2 reflect biology rather than handling. When interpreting EHMT2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.
For multi-run studies, a shared reference condition can keep EHMT2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.
- Targets:
- EHMT2
- Research Area:
- Cancer • Developmental Biology • Epigenetics • Immunology
- Application:
- ChIP • FCM • IF • IHC • IP • WB
- Reactivity:
- Human • Mouse • Rat
- Specificity:
- G9a/EHMT2 Antibody [C3B16] recognizes endogenous levels of total EHMT2/G9A protein.
- Host:
- Rabbit
- Clonality:
- Monoclonal
- Clone:
- C3B16
- UniProt:
- Q96KQ7
- Storage Buffer:
- PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.